Skip to main content
Top
Published in: Archives of Osteoporosis 1-2/2012

Open Access 01-12-2012 | Position Paper

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

Authors: Hajime Orimo, Toshitaka Nakamura, Takayuki Hosoi, Masayuki Iki, Kazuhiro Uenishi, Naoto Endo, Hiroaki Ohta, Masataka Shiraki, Toshitsugu Sugimoto, Takao Suzuki, Satoshi Soen, Yoshiki Nishizawa, Hiroshi Hagino, Masao Fukunaga, Saeko Fujiwara

Published in: Archives of Osteoporosis | Issue 1-2/2012

Login to get access

Abstract

Introduction

In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale 2011 edition and its abridged edition. The present guidelines provide information for the managements of primary osteoporosis in postmenopausal women and men over 50 years old, a summary of the evidence for the treatment of secondary osteoporosis, and a summary of the evidence for the prevention of osteoporosis in younger people.

Method

The present Executive Summary is primarily based on the content of the 2011 Japanese abridged edition. One of the key changes is revision of the criteria for initiation of pharmacological treatment, along with an introduction of the fracture risk factors used in FRAX®. Key figures and tables were selected from the Japanese abridged edition and a reference list was added.

Result and conclusions

The essential points of the Japanese practice guidelines on osteoporosis were translated into English for the first time. It is hoped that the content of the guidelines becomes known throughout the world.
Literature
1.
go back to reference Yoshimura N, Muraki S, Oka H et al (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628PubMedCrossRef Yoshimura N, Muraki S, Oka H et al (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628PubMedCrossRef
2.
go back to reference Orimo H, Yaegashi Y, Onoda T et al (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos 4:71–77PubMedCrossRef Orimo H, Yaegashi Y, Onoda T et al (2009) Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos 4:71–77PubMedCrossRef
3.
go back to reference Yoshimura N, Kinoshita H, Oka H et al (2006) Cumulative incidence and changes in prevalence of vertebral fractures in a rural Japanese community: a 10-year follow-up of the Miyama cohort. Arch Osteoporos. doi:10.1007/s11657-006-0007-0 Yoshimura N, Kinoshita H, Oka H et al (2006) Cumulative incidence and changes in prevalence of vertebral fractures in a rural Japanese community: a 10-year follow-up of the Miyama cohort. Arch Osteoporos. doi:10.​1007/​s11657-006-0007-0
4.
go back to reference Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337PubMedCrossRef Orimo H, Hayashi Y, Fukunaga M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331–337PubMedCrossRef
5.
go back to reference You K (2011) Osteoporos Jpn 19:626, in Japanese You K (2011) Osteoporos Jpn 19:626, in Japanese
6.
go back to reference Nishizawa Y, Ohta h, Miura M, et al. Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 Edition). J Bone Miner Metab. doi:10.1007/s00774-012-0392-y Nishizawa Y, Ohta h, Miura M, et al. Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 Edition). J Bone Miner Metab. doi:10.​1007/​s00774-012-0392-y
7.
go back to reference Orito S, Kuroda T, Onoe Y et al (2009) Age-related distribution of bone and skeletal parameters in 1322 Japanese young women. J Bone Miner Metab 27:698–704PubMedCrossRef Orito S, Kuroda T, Onoe Y et al (2009) Age-related distribution of bone and skeletal parameters in 1322 Japanese young women. J Bone Miner Metab 27:698–704PubMedCrossRef
8.
go back to reference Orimo H, Hosoi T, Fukunaga M (eds) (2009) Manual for osteoporosis screening and health guidance. Life Science Publishing, Tokyo, in Japanese Orimo H, Hosoi T, Fukunaga M (eds) (2009) Manual for osteoporosis screening and health guidance. Life Science Publishing, Tokyo, in Japanese
9.
go back to reference MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213PubMed MacLean C, Newberry S, Maglione M et al (2008) Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148:197–213PubMed
10.
go back to reference Papadimitropoulos E, Wells G, Shea B et al (2002) Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560–569PubMedCrossRef Papadimitropoulos E, Wells G, Shea B et al (2002) Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 23:560–569PubMedCrossRef
11.
go back to reference Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006PubMedCrossRef Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006PubMedCrossRef
12.
go back to reference Matsumoto T, Ito M, Hayashi Y et al (2011) A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures: a randomized, active comparator, double-blind study. Bone 49:605–612PubMedCrossRef Matsumoto T, Ito M, Hayashi Y et al (2011) A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures: a randomized, active comparator, double-blind study. Bone 49:605–612PubMedCrossRef
13.
go back to reference Cockayne S, Adamson J, Lanham-New S et al (2009) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256–1261CrossRef Cockayne S, Adamson J, Lanham-New S et al (2009) Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256–1261CrossRef
14.
go back to reference Hagino H, Nishizawa Y, Sone T et al (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078–1084PubMedCrossRef Hagino H, Nishizawa Y, Sone T et al (2009) A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis. Bone 44:1078–1084PubMedCrossRef
15.
go back to reference Matsumoto T, Hagino H, Shiraki M et al (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429–1437PubMedCrossRef Matsumoto T, Hagino H, Shiraki M et al (2009) Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study. Osteoporos Int 20:1429–1437PubMedCrossRef
16.
go back to reference Orimo H, Morii H, Inoue T et al (1996) Effect of elcatonin on involutional osteoporosis. J Bone Miner Metab 14:73–78CrossRef Orimo H, Morii H, Inoue T et al (1996) Effect of elcatonin on involutional osteoporosis. J Bone Miner Metab 14:73–78CrossRef
17.
go back to reference Nakano T (2011) Clinical effect of calcitonin (elcatonin) on acute pain for osteoporotic vertebral fracture: semi blind randomized controlled trial. Osteoporos Jpn 19:279 Nakano T (2011) Clinical effect of calcitonin (elcatonin) on acute pain for osteoporotic vertebral fracture: semi blind randomized controlled trial. Osteoporos Jpn 19:279
18.
go back to reference Orimo H, Nakamura T, Fukunaga M et al (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)–02. Curr Med Res Opin 27:1273–1284PubMedCrossRef Orimo H, Nakamura T, Fukunaga M et al (2011) Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT)–02. Curr Med Res Opin 27:1273–1284PubMedCrossRef
Metadata
Title
Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary
Authors
Hajime Orimo
Toshitaka Nakamura
Takayuki Hosoi
Masayuki Iki
Kazuhiro Uenishi
Naoto Endo
Hiroaki Ohta
Masataka Shiraki
Toshitsugu Sugimoto
Takao Suzuki
Satoshi Soen
Yoshiki Nishizawa
Hiroshi Hagino
Masao Fukunaga
Saeko Fujiwara
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Archives of Osteoporosis / Issue 1-2/2012
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-012-0109-9

Other articles of this Issue 1-2/2012

Archives of Osteoporosis 1-2/2012 Go to the issue